Standard BioTools Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Standard BioTools ( NASDAQ:LAB ) Full Year 2023 Results Key Financial Results Revenue: US$106.3m (up 8.6% from FY...
Stay updated with breaking news from Standard Biotools. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Standard BioTools ( NASDAQ:LAB ) Full Year 2023 Results Key Financial Results Revenue: US$106.3m (up 8.6% from FY...
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Merger with SomaLogic Marks a Strategic Milestone for the Life Sciences Tools Provider
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that
Standard BioTools Inc. ( NASDAQ:LAB ) shareholders should be happy to see the share price up 14% in the last month. But...